Active Watch List: Sorrento Therapeutics, Inc. (NASDAQ:SRNE), Jaguar Animal Health, Inc. (NASDAQ:JAGX), Plug Power Inc. (NASDAQ:PLUG), Windstream Holdings, Inc. (NASDAQ:WIN), Epizyme (NASDAQ:EPZM)

Sorrento Therapeutics, Inc. (NASDAQ:SRNE) belongs to Healthcare sector. Its weekly performance is 2.46%. On last trading day company shares ended up $17.09. Sorrento Therapeutics, Inc. (NASDAQ:SRNE) distance from 50-day simple moving average (SMA50) is 22.27%. Globavir Biosciences, Inc. and Sorrento Therapeutics, Inc. (NASDAQ:SRNE) announced that the companies have entered into an agreement under which Globavir exclusively licensed its novel oncology compound, BC001, to Sorrento Therapeutics.

Jaguar Animal Health, Inc. (NASDAQ:JAGX) shares moved up 5.13% in last trading session and ended the day at $5.23. Its return on assets is -336.50%. On July 07, Jaguar Animal Health, Inc. (NASDAQ:JAGX) announced that it has appointed Dr. Victoria Lewis as Chief of Clinical Development. Dr. Lewis will oversee the planning, strategic development, and operation of the Company’s expanding clinical initiatives.

On 10 July, Plug Power Inc. (NASDAQ:PLUG) belongs to Technology sector. Its net profit margin is -35.10% and weekly performance is -1.72%. On last trading day company shares ended up $2.28. Plug Power Inc. (NASDAQ:PLUG) distance from 50-day simple moving average (SMA50) is -11.72%. On July 07, Plug Power Inc. (NASDAQ:PLUG) highlighted strong fuel cell and hydrogen infrastructure shipments and installations in the second quarter of 2015 allowing for a record revenue quarter. The company is on track to achieve its previously announced 2015 financial targets.

Windstream Holdings, Inc. (NASDAQ:WIN) belongs to Technology sector. Its net profit margin is -0.90% and weekly performance is -8.24%. On last trading day company shares ended up $5.68. Windstream Holdings, Inc. (NASDAQ:WIN) distance from 50-day simple moving average (SMA50) is -28.24%. Windstream Holdings, Inc. (NASDAQ:WIN) will hold a conference call at 7:30 a.m. CDT on Aug. 6 to review the company’s second-quarter earnings results.

Epizyme, Inc. (NASDAQ:EPZM) belongs to Healthcare sector. Its weekly performance is 3.13%. On last trading day company shares ended up $23.42. Epizyme, Inc. (NASDAQ:EPZM) distance from 50-day simple moving average (SMA50) is 17.68%. Epizyme, Inc. (NASDAQ:EPZM) announced that it has amended and restated its agreement with Celgene Corporation to extend the research collaboration between the two companies for at least three additional years. Under the collaboration, Celgene will have the option to license histone methyltransferase (HMT) inhibitors being developed by Epizyme against three predefined targets.

Leave a Reply

Your email address will not be published. Required fields are marked *